Laryngoscope Market Report 2025

This Laryngoscope market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The laryngoscope market size has grown rapidly in recent years. It will grow from $0.3 billion in 2024 to $0.33 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to medical advancements, anesthesia and intubation, healthcare infrastructure development, training and education.

The laryngoscope market size is expected to see rapid growth in the next few years. It will grow to $0.49 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to aging population, technological innovation, telemedicine and remote consultations, demand for minimally invasive techniques. Major trends in the forecast period include video laryngoscopy, rapid advancements in technology, portability and compact design, disposable laryngoscopes.

The rising prevalence of laryngeal cancers, infections, and chronic respiratory diseases is a significant factor anticipated to drive the growth of the laryngoscope market. Laryngeal cancer, a type of head and neck cancer, occurs when abnormal (malignant) cells develop in the larynx. For example, in 2024, the American Cancer Society (ACS), a US-based health organization, reported that the estimated number of new laryngeal cancer cases in the United States rose to 12,650, compared to 12,380 in 2023. Consequently, the increasing incidence of laryngeal cancer has heightened the demand for laryngoscopes, thereby contributing to the expansion of the laryngoscope market.

Additionally, the growing prevalence of respiratory diseases is expected to further fuel the laryngoscope market's expansion. Respiratory diseases encompass both short-term and chronic ailments that affect the respiratory system. These diseases include acute respiratory conditions like bronchitis, pneumonia, influenza, and chronic respiratory ailments such as chronic obstructive pulmonary disease. Laryngoscopes are used not only to diagnose respiratory disorders like dysphonia, laryngitis, and laryngeal cancer but also to secure the airways of patients with respiratory conditions that require intubation, including tuberculosis, COVID-19, and Ebola. This intubation process reduces the release of aerosols and transmission of pathogens to healthcare professionals. For instance, according to the Australian Institute of Health and Welfare in June 2023, respiratory disorders accounted for 7.3% of the total disease burden in 2022, making them a significant health concern. These respiratory disorders were ranked as the eighth most dominant disease category, following cancer. Therefore, the increasing prevalence of respiratory diseases is a driving force behind the laryngoscope market.

The laryngoscope market is witnessing a significant trend with the emergence of robot-assisted laryngoscopy. This innovation is driven by the increasing complexity and risks associated with advanced medical procedures. Robot-assisted laryngoscopy offers a reliable solution that enhances precision and geometric accuracy, reducing the workload on medical specialists and elevating patient care standards. Robotic systems facilitate faster skill development compared to manual procedures, ultimately leading to improved performance and safety. For example, Johns Hopkins University has developed a robotic laryngoscope that grants surgeons better access to the larynx or voice box, allowing for more precise and controlled procedures.

In the laryngoscope market, major companies are focused on introducing innovative products tailored to the needs of their existing clientele. An example of such innovation is the GlideScope Go 2 handheld video laryngoscope. This handheld device incorporates a camera and video screen, offering portability and enabling healthcare professionals to visualize the larynx and vocal cords without the need for precise alignment of the oral-pharyngeal and laryngeal axes. For instance, Verathon Inc., a US-based medical equipment manufacturing company, launched the GlideScope Go 2 in September 2023. This advanced portable video laryngoscope is designed for urgent and critical situations, providing reliability and performance in a compact form. The device features magnetic QuickConnect technology for effortless and secure connections, ensuring medical practitioners can focus more on patient care. GlideScope Go 2 is compatible with Spectrum QC and Video Baton QC Large with GVL Stats, offering enhanced capabilities for healthcare professionals.

Major companies operating in the laryngoscope market include Ambu A/S, Hill-Rom Holdings Inc., KARL STORZ GmbH & Co. KG, Medtronic PLC, Olympus Corporation, HOYA Corporation, Roper Technologies Inc., Richard Wolf GmbH, Schoelly Fiberoptic GmbH, Welch Allyn Inc., Timesco Healthcare Ltd., GIMMI GmbH, Zhejiang Tiansong Medical Instrument Co.Ltd., XION GmbH, HEINE OPTOTECHNIK GmbH & Co. KG, Truphatek International Ltd., Kangji Medical, Shenda Endoscope, Rudolf Riester GmbH, Baxter International Inc., Nihon Kohden, Teleflex Incorporated, BPL Group, Clarus Medical LLC, SunMed LLC, Vyaire Medical Inc., Flexicare Medical Ltd., IntuBrite LLC.

A laryngoscope is a medical device utilized for the examination and visualization of the larynx and vocal cords within the throat. It plays a critical role during procedures like tracheal intubation, particularly for patients requiring ventilator support.

The primary types in the laryngoscope market are indirect laryngoscopes and direct laryngoscopes. Direct laryngoscopy is a procedure that enables the visualization of the larynx, commonly employed during general anesthesia and various surgical procedures. The products within this market include video laryngoscopes, standard laryngoscopes, and fiber-optic laryngoscopes. End-users of laryngoscopes encompass hospitals, clinics, and medical examination centers, where these devices are integral for diagnostic and therapeutic purposes.

The laryngoscopes market research report is one of a series of new reports that provides laryngoscope market statistics, including laryngoscope industry size, regional shares, competitors with a laryngoscope market share, detailed laryngoscope market segments, market trends and opportunities, and any further data you may need to thrive in the laryngoscope industry. This laryngoscope market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Asia-Pacific was the largest region in the laryngoscopes market in 2024. North America was the second largest region in the laryngoscope market. The regions covered in the laryngoscope market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the laryngoscope market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The laryngoscopes market consists of sales of fiber optic laryngoscopes, video laryngoscopes, and standard/conventional laryngoscopes. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.